At $550 A Month, New Menopause Hot Flash Drug May Be Out Of Reach For Many Women

Heralded as the first and only treatment to block a source of hot flashes in menopausal women, recently approved Veozah (fezolinetant) faces patient access challenges.

Source: Forbes.com Healthcare News - October 24, 2023 Category: Pharmaceuticals Authors: Joshua Cohen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news